• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有代表性的服用地高辛的成年人群的血清地高辛浓度。

Serum digoxin concentrations in a representative digoxin-consuming adult population.

作者信息

Impivaara O, Iisalo E

出版信息

Eur J Clin Pharmacol. 1985;27(6):627-32. doi: 10.1007/BF00547039.

DOI:10.1007/BF00547039
PMID:3987767
Abstract

As part of health examination of a representative sample of an adult population (n = 8000) serum digoxin concentration was measured in 661 patients on continuous digoxin therapy. The prescribed mean daily dose of digoxin was significantly higher in men (223 micrograms) than in women (201 micrograms); the dose significantly decreased with increasing age. The mean serum digoxin concentration was the same in men and women and it differed insignificantly between age groups, although older persons tended to have a higher concentration. The age - adjusted mean steady state digoxin concentration was 1.02 ng/ml in men and 0.98 ng/ml in women; in about 60% the concentration was within the "therapeutic" range (0.80-2.00 ng/ml). The concentrations were clearly related to daily dose of digoxin. At equal dose levels old persons tended to have higher concentrations than younger persons. The interindividual variation in serum digoxin concentrations was very wide. However, when digoxin measurements in the same subjects were repeated about three months later, a good correlation between the two measurements was found. The interval between the last dose of digoxin and the collection of blood (up to 41 h) had relatively little effect on individual serum digoxin concentrations. Patients on concomitant thiazide or loop diuretic therapy had the same mean serum digoxin concentration as those not-receiving a diuretic. The mean concentration was significantly higher in patients taking a thiazide or loop diuretic combined with triamterene. The difference may have been due to an interaction between triamterene and digoxin.

摘要

作为对成年人群代表性样本(n = 8000)进行健康检查的一部分,对661名持续接受地高辛治疗的患者测定了血清地高辛浓度。男性地高辛的规定平均日剂量(223微克)显著高于女性(201微克);剂量随年龄增长而显著降低。男性和女性的平均血清地高辛浓度相同,不同年龄组之间差异不显著,尽管老年人的浓度往往较高。年龄校正后的男性地高辛平均稳态浓度为1.02纳克/毫升,女性为0.98纳克/毫升;约60%的浓度在“治疗”范围内(0.80 - 2.00纳克/毫升)。浓度与地高辛的日剂量明显相关。在相同剂量水平下,老年人的浓度往往高于年轻人。血清地高辛浓度的个体间差异非常大。然而,大约三个月后对同一受试者重复进行地高辛测量时,发现两次测量之间有良好的相关性。地高辛最后一剂与采血之间的间隔时间(最长41小时)对个体血清地高辛浓度的影响相对较小。接受噻嗪类或襻利尿剂联合治疗的患者的平均血清地高辛浓度与未接受利尿剂治疗的患者相同。服用噻嗪类或襻利尿剂联合氨苯蝶啶的患者的平均浓度显著更高。这种差异可能是由于氨苯蝶啶与地高辛之间的相互作用所致。

相似文献

1
Serum digoxin concentrations in a representative digoxin-consuming adult population.具有代表性的服用地高辛的成年人群的血清地高辛浓度。
Eur J Clin Pharmacol. 1985;27(6):627-32. doi: 10.1007/BF00547039.
2
Serum digoxin levels using an 125I-labelled antigen: Validation of method and observations on cardiac patients.使用125I标记抗原测定血清地高辛水平:方法验证及对心脏病患者的观察
Am Heart J. 1975 Jan;89(1):79-86. doi: 10.1016/0002-8703(75)90013-7.
3
Magnesium and potassium-sparing diuretics.镁剂和保钾利尿剂。
Magnesium. 1986;5(5-6):282-92.
4
Biochemical basis of diuretic action.利尿剂作用的生化基础。
J Clin Pharmacol. 1977 Oct;17(10 Pt 2):626-41.
5
[Serum digoxin concentration: dependence on body weight and age].[血清地高辛浓度:对体重和年龄的依赖性]
Schweiz Med Wochenschr. 1977 Nov 26;107(47):1695-9.
6
Some observations on serum concentrations of digitoxin and digoxin.关于洋地黄毒苷和地高辛血清浓度的一些观察结果。
Jpn Heart J. 1979 Sep;20(5):623-9. doi: 10.1536/ihj.20.623.
7
Potassium-sparing diuretics: interaction with digoxin in elderly men.保钾利尿剂:老年男性中与地高辛的相互作用。
J Am Geriatr Soc. 1984 Feb;32(2):129-31. doi: 10.1111/j.1532-5415.1984.tb05853.x.
8
Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.肾功能正常和受损患者中地高辛的血药浓度与剂量之间的关系。
Circulation. 1978 Dec;58(6):1196-203. doi: 10.1161/01.cir.58.6.1196.
9
Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals.血清地高辛治疗水平与收缩期时间间期之间的剂量-反应关系。
Am J Cardiol. 1975 Apr;35(4):469-72. doi: 10.1016/0002-9149(75)90828-0.
10
Diuretic-associated hypomagnesemia in the elderly.老年人利尿剂相关性低镁血症
Arch Intern Med. 1987 Oct;147(10):1768-71.

引用本文的文献

1
Prescription monitoring of drug dosages in the county of Jämtland and Sweden as a whole in 1976, 1982 and 1985.1976年、1982年和1985年瑞典耶姆特兰郡及整个瑞典的药物剂量处方监测情况。
Eur J Clin Pharmacol. 1990;38(4):329-34. doi: 10.1007/BF00315570.

本文引用的文献

1
Digoxin and Phenytoin analyses as part of consultations in clinical pharmacology: a study on the use of drugs.作为临床药理学会诊一部分的地高辛和苯妥英分析:一项关于药物使用的研究
Ther Drug Monit. 1981;3(3):259-69. doi: 10.1097/00007691-198103000-00006.
2
Amiloride-induced changes in digoxin dynamics and kinetics: abolition of digoxin-induced inotropism with amiloride.
Clin Pharmacol Ther. 1981 Aug;30(2):172-6. doi: 10.1038/clpt.1981.144.
3
Delayed elimination of triamterene and its active metabolite in chronic renal failure.
Eur J Clin Pharmacol. 1983;24(4):453-6. doi: 10.1007/BF00609885.
4
Serum digoxin determination in outpatients--need for standardization.门诊患者血清地高辛测定——标准化的必要性。
Br J Clin Pharmacol. 1983 Jan;15(1):55-8. doi: 10.1111/j.1365-2125.1983.tb01463.x.
5
Interactions between digoxin and potassium-sparing diuretics.
Clin Pharmacol Ther. 1983 Apr;33(4):418-23. doi: 10.1038/clpt.1983.56.
6
Indications for the measurement of plasma digoxin concentrations.血浆地高辛浓度测定的适应证。
Drugs. 1983 Sep;26(3):230-42. doi: 10.2165/00003495-198326030-00004.
7
Digoxin metabolism in the elderly.老年人地高辛的代谢
Circulation. 1969 Apr;39(4):449-53. doi: 10.1161/01.cir.39.4.449.
8
Serum levels and renal excretion of digoxin in the elderly. A comparison between three different preparations.
Acta Med Scand. 1974 Jul-Aug;196(1-2):59-63. doi: 10.1111/j.0954-6820.1974.tb00968.x.
9
Effect of reserpine, desipramine and phenytoin on digoxin induced arrhythmias and myocardial uptake of digoxin in guinea pigs.
Acta Pharmacol Toxicol (Copenh). 1975 Jul;37(1):8-16. doi: 10.1111/j.1600-0773.1975.tb00816.x.
10
Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.地高辛治疗监测:II. 表观分布容积的决定因素。
Br J Clin Pharmacol. 1977 Apr;4(2):223-7. doi: 10.1111/j.1365-2125.1977.tb00698.x.